

Developer of epigenetic tools for DNA analysis. The company is the developer of the TrueMethyl kit, a rapid method for parallel genome-wide detection of cytosine methylation and hydroxy-methylation. The kits can be used with a variety of common platforms, including next-generation sequencing systems, methylation arrays and targeted assays.
| Headquarter | Jonas Webb Building, Cambridge CB22 3AT United Kingdom |
|---|---|
| Website | www.cambridge-epigenetix.com |
| Founding Date | 2012 |
| Company Status | Private |
CEGX competitors include MWI Veterinary Supply, Advanced Accelerator Applications, and Actinium Pharmaceuticals. CEGX ranks 3rd in Overall Culture Score on Comparably vs its competitors. See below how CEGX compares to its competitors with CEO Rankings, Product & Services, NPS, Pricing, Customer Services, Overall Culture Score, eNPS, Gender and Diversity Scores.
CEGX has 23 employees. 1 employee at CEGX has reviewed CEGX across various culture dimensions, providing their opinions on items ranging from executive ratings to the pace at work. The latest review was months ago.

The prevailing opinion from Comparably users about their company is that it was very prepared on their first day. Employees concluded that their overall onboarding experience was positive. 73% said their direct manager was helpful with their acclimation during the first 90 days. First impressions are important, and how prepared a company is on your first day leaves a lasting impression.
At this moment no CEGX employees have provided insight into whether or not they clearly understand CEGX's KPIs and OKRs.

No Recent Jobs found for CEGX on Comparably
Mark that you are interested and we will alert you when there are new positions available listed on Comparably

What is CEGX address?
CEGX location is at Jonas Webb Building, Cambridge
What is CEGX eNPS?
The eNPS for CEGX is -100
How many employees work in CEGX?
CEGX has 23 employees
Who are CEGX competitors?
CEGX main competitors are MWI Veterinary Supply, Advanced Accelerator Applications, Actinium Pharmaceuticals